What is MaRS EXCITE?

As part of the MaRS Health services, the MaRS Excellence in Clinical Innovation Technology Evaluation (EXCITE) program is a collaboration between a range of stakeholders in the health system that work together to help innovative health technologies get to market faster and improve patient outcomes.

At the end of the program, companies will have a robust evidence package, called the EXCITE core evidentiary bundle, that they can use for both Health Canada licensing and reimbursement and purchasing reviews.

 

Beside device

  • Dr. Murray Krahn interviewed on CBC’s Metro Morning regarding controversial PSA test More...
  • Becton Dickinson to pay $12.2B to acquire medical equipment rival Carefusion More...
  • MedTech Thursday Meetup in Toronto on November 6 More...
  • MaRS EXCITE to help bring innovative stroke recovery device to market More...
  • Kangaroo opening new Toronto West co-working space for young companies More...
  • Synapse Life Sciences Competition Now Open More...
  • Event: Panel on Creating a Health Innovation Ecosystem in the Buffalo-Niagara Region More...
  • Resource: Health Canada Approval Process for Medical Devices More...
  • Report: Transforming Health- Toward decentralized and connected care More...
  • CADTH 25th Anniversary Lecture Series More...